Biomarker‐based definition of limbic‐predominant long‐lasting amnestic mild cognitive impairment
Volume: 16, Issue: S5
Published: Dec 1, 2020
Abstract
Background Previous studies described amnestic Mild Cognitive Impairment (aMCI) subjects with slow rate of cognitive decline, benign disease course associated to FDG‐PET brain hypometabolism in the medial temporal lobe structures. Clinical and post‐mortem studies suggested the presence of both Alzheimer’s disease (AD) and non‐AD pathology. The identification of aMCI with a benign course has relevant consequences both for prognosis and treatment....
Paper Details
Title
Biomarker‐based definition of limbic‐predominant long‐lasting amnestic mild cognitive impairment
Published Date
Dec 1, 2020
Volume
16
Issue
S5
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History